Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 103.09%338.13M | 19.95%353.26M | -76.82%154.24M | -77.85%132.92M | -73.61%166.49M | -67.76%294.5M | 831.08%665.51M | 1,449.70%600.19M | --630.81M | 1,068.12%913.43M |
| Transactional financial assets | -82.19%88.07M | -79.59%85.93M | 120.07%377.19M | 71.58%494.52M | 74.30%494.63M | --420.9M | --171.4M | --288.22M | --283.78M | ---- |
| Notes receivable and accounts receivable | 31.18%263.88M | 37.62%269.13M | 46.37%244.75M | 22.80%246.11M | 5.00%201.16M | 6.60%195.55M | 4.10%167.22M | 9.17%200.42M | --191.57M | 64.14%183.45M |
| -Notes receivable | 43.21%50.92M | 65.28%63.39M | 32.05%61.09M | 44.95%44.63M | 76.26%35.55M | 58.43%38.36M | 33.43%46.27M | -5.03%30.79M | --20.17M | 48.29%24.21M |
| -Accounts receivable | 28.60%212.96M | 30.88%205.73M | 51.84%183.66M | 18.78%201.48M | -3.38%165.6M | -1.28%157.2M | -3.97%120.95M | 12.21%169.63M | --171.4M | 66.85%159.24M |
| Other receivables (including interest and dividends) | 37.99%1.96M | 12.91%1.66M | 0.98%1.79M | 17.04%1.77M | -31.55%1.42M | 14.11%1.47M | 10.12%1.78M | -2.39%1.52M | --2.08M | 39.87%1.29M |
| -Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| -Other receivable | ---- | 12.91%1.66M | ---- | ---- | ---- | 14.11%1.47M | --1.78M | -2.39%1.52M | --2.08M | 39.87%1.29M |
| Contractual assets | 4.81%517.03K | 4.81%517.03K | 98.12%386.62K | 20.23%234.62K | 11.12%493.29K | 14.30%493.29K | -73.58%195.14K | -71.76%195.14K | --443.94K | -11.88%431.59K |
| Advance payment | -29.37%3.56M | -64.04%3.26M | -68.78%1.68M | -16.37%4.18M | -24.62%5.04M | 130.18%9.06M | 14.05%5.38M | 66.97%4.99M | --6.69M | 100.75%3.94M |
| Inventories | 35.52%231.73M | 43.41%206.89M | 36.10%219.81M | 27.35%195.57M | 26.42%171M | 11.13%144.27M | 14.04%161.51M | 3.38%153.57M | --135.26M | 0.66%129.82M |
| Receivable financing | 94.70%190.83M | 51.83%155.61M | 33.99%167.16M | -0.30%91.26M | 12.00%98.01M | 2.23%102.49M | 23.00%124.76M | 8.95%91.54M | --87.51M | 6.57%100.25M |
| Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Non-current assets due within one year | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Other current assets | 203.60%46.43M | 197.01%57.03M | 38.63%24.12M | 41.12%25.68M | 70.52%15.29M | 334.12%19.2M | 134.49%17.4M | 141.71%18.2M | --8.97M | -41.85%4.42M |
| Total current assets | 1.00%1.17B | -4.60%1.13B | -9.43%1.19B | -12.26%1.19B | -14.37%1.15B | -11.15%1.19B | 168.59%1.32B | 190.57%1.36B | --1.35B | 215.29%1.34B |
| Non Current assets | ||||||||||
| Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Other debt investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Other equity investment | -13.76%15.35M | -13.76%15.35M | -10.14%15.99M | --15.99M | --17.8M | --17.8M | --17.8M | ---- | --0 | ---- |
| Other non-current financial assets | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Investment real estate | ---- | ---- | ---- | ---- | -68.00%3.51M | -67.98%3.57M | -67.94%3.62M | -67.92%3.67M | --10.98M | -24.68%11.13M |
| Long-term equity investment | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Fixed assets | ---- | 21.00%356.54M | ---- | ---- | ---- | 79.46%294.66M | ---- | 77.96%274.93M | ---- | 7.99%164.19M |
| Constru in process | ---- | 215.52%223.59M | ---- | ---- | ---- | -23.65%70.86M | ---- | -67.52%20.77M | ---- | 386.23%92.82M |
| Productive biological assets | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Oil and gas assets | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Intangible assets | -0.22%81.68M | 0.16%82.12M | -0.55%82.08M | 94.63%81.99M | 106.55%81.86M | 104.96%81.99M | 113.68%82.53M | 8.16%42.13M | --39.63M | 6.98%40M |
| Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Goodwill | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Long deferred expense | 125.40%41.17M | 54.07%27.27M | 65.23%26.99M | 64.32%24.99M | 21.46%18.27M | 16.13%17.7M | 7.64%16.33M | 8.01%15.21M | --15.04M | 52.82%15.24M |
| Deferred tax assets | 11.26%18.32M | 3.05%18.32M | -34.28%11.42M | -6.29%15.48M | -37.45%16.46M | -16.97%17.77M | -16.31%17.38M | -8.72%16.52M | --26.32M | 9.11%21.41M |
| Usufruct assets | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Other non current assets | -21.91%43.6M | -8.00%42.05M | 162.78%66.38M | 154.84%67.84M | 3,979.33%55.84M | 1,028.80%45.7M | 153.31%25.26M | 388.56%26.62M | --1.37M | 7.33%4.05M |
| Total non current assets | 38.71%824.86M | 39.12%765.24M | 52.54%706.92M | 68.96%675.58M | 64.08%594.66M | 57.68%550.06M | 45.19%463.44M | 30.47%399.86M | --362.43M | 35.91%348.85M |
| Total assets | 13.83%1.99B | 9.24%1.9B | 6.72%1.9B | 6.21%1.87B | 2.26%1.75B | 3.09%1.74B | 119.89%1.78B | 127.19%1.76B | 133.87%1.71B | 147.65%1.69B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -76.19%2.4M | -76.19%2.4M | ---- | --0 | --10.08M | 151.77%10.08M | 399.09%49.96M | --2.29M | --0 | --4M |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Notes payable and accounts payable | 44.97%363.79M | 21.35%341.9M | 24.08%329.77M | 24.60%335.63M | 6.40%250.93M | 12.87%281.73M | 20.64%265.78M | 20.47%269.37M | --235.83M | 40.22%249.6M |
| -Notes payable | 14.41%142.99M | -2.73%129.67M | 5.93%159.8M | 12.26%142.41M | 14.04%124.98M | 6.48%133.31M | 20.95%150.85M | 38.82%126.86M | --109.59M | 39.96%125.2M |
| -Accounts payable | 75.31%220.8M | 42.98%212.23M | 47.89%169.97M | 35.58%193.22M | -0.23%125.95M | 19.31%148.43M | 20.25%114.93M | 7.79%142.51M | --126.24M | 40.49%124.41M |
| Contract liabilities | 28.42%10.54M | -16.01%5.29M | 75.30%13.14M | 23.10%8.21M | 33.89%8.21M | 4.18%6.3M | -11.04%7.5M | 8.17%6.67M | --6.13M | 6.61%6.05M |
| Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Salaries payable | 26.51%22.99M | 27.87%19.48M | 59.18%17.41M | 24.72%23.68M | 50.21%18.17M | 55.51%15.23M | -4.62%10.94M | 25.23%18.99M | --12.1M | -29.39%9.8M |
| Taxs payable | 48.75%11.7M | 0.11%10.71M | 12.80%10.21M | 38.15%7.67M | -72.88%7.86M | 69.60%10.7M | -15.13%9.05M | -69.29%5.56M | --29M | -70.09%6.31M |
| Other payable (including interest and dividends) | -40.04%11.74M | 15.69%11.54M | -33.91%12.24M | -34.84%11.9M | -9.30%19.59M | -66.90%9.98M | 107.44%18.52M | 163.42%18.27M | --21.59M | 333.51%30.15M |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| -Other payable | ---- | 15.69%11.54M | ---- | ---- | ---- | -66.90%9.98M | --18.52M | 163.42%18.27M | --21.59M | 333.51%30.15M |
| Hold and for sell liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Non current liabilities due within one year | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Other current liabilities | 161.61%8.06M | 114.31%4.31M | 392.66%4.9M | 176.74%3.17M | 164.32%3.08M | -11.87%2.01M | -82.84%995.28K | -61.90%1.15M | --1.17M | 118.52%2.28M |
| Total current liabilities | 35.64%431.22M | 17.73%395.64M | 6.87%387.66M | 21.09%390.27M | 3.96%317.93M | 9.04%336.04M | 31.62%362.73M | 18.07%322.29M | --305.82M | 35.98%308.19M |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Bonds payable | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Preferred stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Perpetual Debt | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Long term salaries pay | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Estimate liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Deferred tax liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.08M | -15.69%3.28M |
| Long term deferred income | 275.42%24.94M | 90.57%12.92M | 109.43%10.66M | 111.55%10.9M | 23.71%6.64M | 16.21%6.78M | -14.40%5.09M | -14.73%5.15M | --5.37M | -32.77%5.84M |
| Lease liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Total non current liabilities | 275.42%24.94M | 90.57%12.92M | 109.43%10.66M | 111.55%10.9M | -21.40%6.64M | -25.61%6.78M | -47.00%5.09M | -14.73%5.15M | --8.45M | -27.48%9.12M |
| Total liabilities | 40.54%456.16M | 19.18%408.56M | 8.29%398.33M | 22.52%401.17M | 3.28%324.57M | 8.04%342.82M | 28.97%367.82M | 17.36%327.44M | 20.05%314.27M | 32.65%317.31M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%103.38M | 0.00%103.38M | 0.00%103.38M | 0.00%103.38M | 0.00%103.38M | 0.00%103.38M | 33.39%103.38M | 33.39%103.38M | --103.38M | 33.39%103.38M |
| Other equity instruments | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| -Equity of prefer stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| -Equity of Perpetual debt | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Capital reserve funds | 0.93%848.45M | 0.00%840.65M | 0.00%840.65M | 0.00%840.65M | 0.00%840.65M | 0.00%840.65M | 1,763.19%840.65M | 1,763.19%840.65M | --840.65M | 1,763.19%840.65M |
| Surplus reserve funds | 24.20%43.95M | 24.20%43.95M | 24.20%43.95M | 24.20%43.95M | 28.79%35.38M | 28.79%35.38M | 28.79%35.38M | 28.79%35.38M | --27.47M | 37.15%27.47M |
| Retained profit | 17.59%585.26M | 18.81%557.52M | 17.73%566.78M | 18.12%533.72M | 17.45%497.72M | 18.18%469.26M | 28.88%481.42M | 30.96%451.83M | --423.76M | 32.85%397.05M |
| Less:Treasury stock | -15.85%45.02M | 0.00%53.5M | 6.82%53.5M | --53.5M | --53.5M | --53.5M | --50.09M | ---- | --0 | ---- |
| Other composite income | ---2.22M | ---2.06M | ---1.53M | ---1.53M | ---- | ---- | --0 | ---- | --0 | ---- |
| Ordinary risk reserve funds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Specific reserves | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
| Shareholders equity without minority interests | 7.74%1.53B | 6.79%1.49B | 6.31%1.5B | 2.47%1.47B | 2.03%1.42B | 1.94%1.4B | 169.41%1.41B | 189.07%1.43B | --1.4B | 209.96%1.37B |
| Minority interests | ---70.21 | ---- | ---- | --0 | ---- | --0 | --0 | ---- | --0 | ---- |
| Total shareholder equity | 7.74%1.53B | 6.79%1.49B | 6.31%1.5B | 2.47%1.47B | 2.03%1.42B | 1.94%1.4B | 169.41%1.41B | 189.07%1.43B | 197.37%1.4B | 209.96%1.37B |
| Total liabilityies and equity | 13.83%1.99B | 9.24%1.9B | 6.72%1.9B | 6.21%1.87B | 2.26%1.75B | 3.09%1.74B | 119.89%1.78B | 127.19%1.76B | 133.87%1.71B | 147.65%1.69B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.